4.7 Article

Selective degradation of AR-V7 to overcome castration resistance of prostate cancer

Related references

Note: Only part of the references are listed.
Article Oncology

KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer

Lin Gao et al.

Summary: The study reveals that KIF15 contributes to enzalutamide resistance by enhancing AR signaling, and suggests that cotargeting KIF15 and AR may be an effective therapeutic strategy for prostate cancer.

CANCER RESEARCH (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Biochemistry & Molecular Biology

A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance

Yuning Liao et al.

Summary: The study revealed the key role of the molecular chaperone GRP75 in maintaining the protein stability of SIX1 in prostate cancer cells, inhibiting tumor growth and overcoming castration resistance by recruiting the deubiquitinating enzyme USP1 to inhibit polyubiquitination of SIX1. The expression of GRP75, USP1, and SIX1 proteins are positively correlated in clinical prostate cancer tissues.

ONCOGENE (2021)

Article Oncology

Nobiletin downregulates the SKP2-p21/p27-CDK2 axis to inhibit tumor progression and shows synergistic effects with palbociclib on renal cell carcinoma

Tingting Chen et al.

Summary: The study found that nobiletin inhibits tumor progression in renal cell carcinoma by downregulating the SKP2-p21/p27-CDK2 axis, and shows synergistic tumor inhibition effects when used in combination with the CDK4/6 inhibitor, palbociclib.

CANCER BIOLOGY & MEDICINE (2021)

Article Immunology

Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells

Asuman Deveci Ozkan et al.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2020)

Review Biochemistry & Molecular Biology

The emerging role of paraptosis in tumor cell biology: Perspectives for cancer prevention and therapy with natural compounds

Fabrizio Fontana et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Article Oncology

Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer

Yuning Liao et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Review Biochemistry & Molecular Biology

Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease

Akira Nakajima et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemistry & Molecular Biology

Harnessing the anti-cancer natural product nimbolide for targeted protein degradation

Jessica N. Spradlin et al.

NATURE CHEMICAL BIOLOGY (2019)

Review Urology & Nephrology

Genomic Markers in Prostate Cancer Decision Making

Vito Cucchiara et al.

EUROPEAN UROLOGY (2018)

Article Pathology

Optimal Reference Gene Selection for Expression Studies in Human Reticulocytes

Anu Aggarwal et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2018)

Article Multidisciplinary Sciences

Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13

Zhong Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer

Christine Henzler et al.

NATURE COMMUNICATIONS (2016)

Article Oncology

Global Cancer Statistics, 2012

Lindsey A. Torre et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2015)

Article Multidisciplinary Sciences

Substrate degradation by the proteasome: A single-molecule kinetic analysis

Ying Lu et al.

SCIENCE (2015)

Article Oncology

USP22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer Progression

Randy S. Schrecengost et al.

CANCER RESEARCH (2014)

Article Medicine, General & Internal

AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer

Emmanuel S. Antonarakis et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Pharmacology & Pharmacy

Nobiletin suppresses cell viability through AKT Pathways in PC-3 and DU-145 prostate cancer cells

Jianchu Chen et al.

BMC PHARMACOLOGY & TOXICOLOGY (2014)

Article Biochemistry & Molecular Biology

Citrus nobiletin suppresses inducible nitric oxide synthase gene expression in interleukin-1β-treated hepatocytes

Emi Yoshigai et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Review Pharmacology & Pharmacy

Androgen receptors in hormone-dependent and castration-resistant prostate cancer

Ayesha A. Shafi et al.

PHARMACOLOGY & THERAPEUTICS (2013)

Review Oncology

Alternatively spliced androgen receptor variants

Scott M. Dehm et al.

ENDOCRINE-RELATED CANCER (2011)

Article Biochemistry & Molecular Biology

The Tightly Controlled Deubiquitination Activity of the Human SAGA Complex Differentially Modifies Distinct Gene Regulatory Elements

Guillaume Lang et al.

MOLECULAR AND CELLULAR BIOLOGY (2011)

Article Biochemistry & Molecular Biology

Nobiletin metabolite, 3′,4′-dihydroxy-5,6,7,8-tetramethoxyflavone, inhibits LDL oxidation and down-regulates scavenger receptor expression and activity in THP-1 cells

Ya-Hsuan Lo et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)

Article Oncology

Integrative Genomic Profiling of Human Prostate Cancer

Barry S. Taylor et al.

CANCER CELL (2010)

Article Medicine, Research & Experimental

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

Shihua Sun et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Biochemistry & Molecular Biology

Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin

Tilman Schneider-Poetsch et al.

NATURE CHEMICAL BIOLOGY (2010)

Review Cell Biology

Breaking the chains: structure and function of the deubiquitinases

David Komander et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)

Article Biochemistry & Molecular Biology

Flavonoid composition of fruit tissues of Citrus species

Y Nogata et al.

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2006)

Review Endocrinology & Metabolism

Androgen receptor in prostate cancer

CA Heinlein et al.

ENDOCRINE REVIEWS (2004)